Tacrolimus intrapatient variability and rejection are associated with inferior allograft outcomes after kidney transplantation
Hence, graft losses were predominantly alloimmune mediated, often associated with non-adherence, and were predicted by tacrolimus IPV at 1 year.
Authors
- Katie Butler
- Alice Gage
- Graham Shirling
- Mark Harber (ORCID: https://orcid.org/0000-0002-5441-2452)
- Rhys Evans (ORCID: https://orcid.org/0000-0001-7543-2041)
- Maryam Javed (ORCID: https://orcid.org/0000-0002-3115-282X)
- Abigail Hobill (ORCID: https://orcid.org/0000-0002-9425-9544)
- Ria Nagpal (ORCID: https://orcid.org/0000-0002-1114-3483)
- Gareth Jones (ORCID: https://orcid.org/0000-0003-4601-1269)
- Amy Needleman
- Azhar Ali Khan (ORCID: https://orcid.org/0000-0002-9982-7061)
- Ray Fernando
- Felix Karst
- Nicola Thal
- Mya Hmun
- Aruna Sanghera
Institutions
- Royal Free London NHS Foundation Trust (GB)
- Anthony Nolan (GB)
- The Royal Free Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- Frontiers in Nephrology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.3389/fneph.2025.1666191
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00